Determining the neurodevelopmental cell type specific regulatory networks impacted in Down syndrome

Information

  • Research Project
  • 10304101
  • ApplicationId
    10304101
  • Core Project Number
    R03NS123969
  • Full Project Number
    1R03NS123969-01
  • Serial Number
    123969
  • FOA Number
    RFA-OD-20-006
  • Sub Project Id
  • Project Start Date
    9/1/2021 - 2 years ago
  • Project End Date
    8/31/2023 - 8 months ago
  • Program Officer Name
    RIDDLE, ROBERT D
  • Budget Start Date
    9/1/2021 - 2 years ago
  • Budget End Date
    8/31/2023 - 8 months ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
  • Award Notice Date
    8/23/2021 - 2 years ago

Determining the neurodevelopmental cell type specific regulatory networks impacted in Down syndrome

PROJECT SUMMARY/ABSTRACT Down syndrome is the most prevalent genetic condition in humans and a major cause of intellectual disability. Although the severity and extent of phenotypes present in Down syndrome partially result from an extra copy of chromosome 21, details regarding the biological mechanisms and the emergence of atypical development is not understood. To address this significant gap in knowledge, we previously created a ?Developmental Cell Atlas of Down Syndrome? by using single-cell RNA-sequencing to profile the transcriptomes of over 700,000 cells derived from multiple tissues. This proposal represents our ongoing efforts to characterize the molecular and cellular identity of cellular phenotypes present in the developing brain in Down syndrome. In Aim 1, we will map the Down syndrome cells onto a reference framework of the developing human brain by pooling existing single-cell RNA-sequencing data. In Aim 2, we will use our established human brain functional genomics pipeline to infer cell-type-specific gene regulatory networks altered in Down syndrome. Leveraging existing data, this study will provide critical information about the emergence and regulation of early brain development in Down syndrome that can be used to elucidate the molecular mechanisms underlying early neuropathology and to benchmark model systems for disease relevant neuronal phenotypes.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R03
  • Administering IC
    NS
  • Application Type
    1
  • Direct Cost Amount
    255500
  • Indirect Cost Amount
    110625
  • Total Cost
    366125
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
    OD:366125\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SEATTLE CHILDREN'S HOSPITAL
  • Organization Department
  • Organization DUNS
    048682157
  • Organization City
    SEATTLE
  • Organization State
    WA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    981053901
  • Organization District
    UNITED STATES